MAXY - Maxygen, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MAXY - Maxygen, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: westpacific who started this subject	11/26/2001 5:45:52 AM
From: nigel bates	Read Replies (1) of 262

Accelerated evolution... the-scientist.com The Scientist 15[23]:12, Nov. 26, 2001 ...Philadelphia-based Morphotek creates genetically altered host organisms using morphogenics, a technology that alters the genome of a wide range of host cells including microbes, plants, and mammals. The resulting evolution is accelerated and the gene pool is then skimmed for the offspring that exhibit viable traits, say company officials. "Morphogenics works on all organisms," explains Morphotek CEO Nicholas Nicoladies. "The power of our technology is applicable for a wide range of manufacturing and gene discovery ... this gives us a wide variety of clients." Morphotek recently announced its first collaborative research agreement, signed Sept. 27, with Wyeth-Ayerst Laboratories to develop cell lines in oncology research. Says Wyeth-Ayerst spokesman Douglas Petkus: "We were aware of their patented technology and felt it would be viable and of great worth to our project." ...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next